Address

ValenzaBio
6701 Democracy Blvd Suite 300
Bethesda, MD 20817
United States

Open map

KANDO id: 1051437

Corporate information

Official name
ValenzaBio Inc.

Company type

antibody for inflammatory eye disease

Overview

ValenzaBio is a privately-held biopharmaceutical company developing therapies for autoimmune and inflammatory diseases. With a pipeline of differentiated monoclonal antibodies targeting clinically-validated mechanisms of action, we seek to provide improved therapies for patients with limited treatment options. Based in Bethesda, Maryland, in the heart of the capital biotech community, we strive to work collaboratively with all stakeholders while keeping our research and development efforts focused on the needs of patients.



Funding rounds

Series A USD 70,000,000


( )

Profile Country Notes
Fidelity Management and Research Co (FMR Co) Initial investment. Led the round.
Ikarian Healthcare Fund LP Initial investment.
Opaleye LP Initial investment.
Janus Henderson Individual investor. Initial investment.


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials